This project is being carried out through a Strategic Award from the Wellcome Trust to Steve Jackson, Mike Stratton, Peter Campbell, Serena Nik-Zainal and others. This grant is to fund work aimed at i
Percentages are the proportion of tumors having a mutation within a subtype, e.g. 37% of Bronchioid tumors have an EGFR mutation in the discovery cohorts. Corresponding numbers of patients with gene m
aWT: no signiffcant difference to WT cells; Intermediate: 80-40% of WT characteristic; Weak: less than 40% of WT characteristic.bMean sizes were found slightly variable within a range between 48-35 nm